Skip to main content

Table 3 Association between OABSS and dyskinesia in PD patients

From: Unraveling the interplay between dyskinesia and overactive bladder symptoms in Parkinson’s disease: a comprehensive cohort study based on the long-term follow-up database of Parkinson’s disease

 

Over-Active Bladder Syndrome Score (OABSS)

P trend

Per 1 SD

Dyskinesia vs. Non-dyskinesia

 OABSS interval

0–2

3–5

6–15

  

 Median OABSS

2

5

10

  

 Dyskinesia Events, n (%)

51(9.68)

26 (7.65)

221(46.92)

  

Model 1

1

0.773(0.466,1.254)ns

8.251(5.912,11.700)***

<0.001

3.857(3.313,4.522)

Model 2

1

0.678(0.399,1.126)ns

6.028(4.219,8.739)***

<0.001

3.522(2.987,4.185)

Model 3

1

0.561(0.317,0.971)*

4.376(2.772,6.989)***

<0.001

3.838(3.090,4.816)

  1. Model 1: unadjusted model (Dyskinesia vs. non-dyskinesia ~ OABSS). Model 2: adjusted for Onset, Duration, LEDD. Model 3: further adjusted for UPDRSI, UPDRSII, UPDRSIII, MMSE, MoCA, NMSQ. Abbreviations: SD Standard deviation, Per 1 SD Per One Standard Deviation, OABSS Over-Active Bladder Syndrome Score, Duration Disease duration, H-Y Hoehn and Yahr, LEDD Levodopa equivalent daily dose, UPDRS The Unified Parkinson’s Disease Rating Scale, MMSE Mini-Mental State Examination, MoCA Montreal Cognitive Assessment, NMSQ None Motor Symptom Questionnaire. OABSS ≤ 2 without OAB; 3–5 with mild OAB; 6–11 with moderate to severe OAB
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us